Assessment of Cardiac Allograft Vasculopathy Late After Heart Transplantation: When Is Coronary Angiography Necessary?

Journal of Heart and Lung Transplantation

Volumn 25, Issue 9, 2006, Pages 1103-1108

  Störk, Stefan ^a   Behr, Thomas M ^a   Birk, Michael ^b   Überfuhr, Peter ^b   Klauss, Volker ^b   Spes, Christoph H ^c   Angermann, Christiane E ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Munich Municipal Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; DOBUTAMINE;

ADULT; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; GRAFT RECIPIENT; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; STAINING; STRESS ECHOCARDIOGRAPHY; UNIVARIATE ANALYSIS;

ADULT; AGE FACTORS; ANTITHROMBIN III; CORONARY ANGIOGRAPHY; CORONARY VESSELS; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; PROGNOSIS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR DISEASES;

EID: 33748193660     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.05.009     Document Type: Article

References (24)

1. Trulock E.P., Edwards L.B., Taylor D.O., et al. The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 23 (2004) 804-815
2. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Heart Lung Transplant 23 suppl 5 (2004) S187-S193
3. Costanzo M.R., Naftel D.C., Pritzker M.R., et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 17 (1998) 744-753
4. Radovancevic B., McGiffin D.C., Kobashigawa J.A., et al. Retransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study. J Heart Lung Transplant 22 (2003) 862-868
5. Weis M., and von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 96 (1997) 2069-2077
6. Labarrere C.A. Anticoagulation factors as predictors of transplant-associated coronary artery disease. J Heart Lung Transplant 19 (2000) 623-633
7. Labarrere C.A., Nelson D.R., and Park J.W. Pathologic markers of allograft arteriopathy: insight into the pathophysiology of cardiac allograft chronic rejection. Curr Opin Cardiol 16 (2001) 110-117
8. Rickenbacher P.R., Pinto F.J., Chenzbraun A., et al. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. JAMA 25 (1995) 171-177
9. Costello J.M., Wax D.F., Binns H.J., Backer C.L., Mavroudis C., and Pahl E. A comparison of intravascular ultrasound with coronary angiography for evaluation of transplant coronary disease in pediatric heart transplant recipients. J Heart Lung Transplant 22 (2003) 44-49
10. Sharples L.D., Jackson C.H., Parameshwar J., Wallwork J., and Large S.R. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy. Transplantation 76 (2003) 679-682
11. Hausmann D., Erbel R., Alibelli-Chemarin M.J., et al. The safety of intracoronary ultrasound. A multicenter survey of 2207 examinations. Circulation 91 (1995) 623-630
12. Aranda Jr. J.M., and Hill J. Cardiac transplant vasculopathy. Chest 118 (2000) 1792-1800
13. Spes C.H., Klauss V., Mudra H., et al. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound. Circulation 100 (1999) 509-515
14. Behr T.M., Feucht H.E., Richter K., et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 18 (1999) 904-912
15. Labarrere C.A., Torry R.J., Nelson D.R., et al. Vascular antithrombin and clinical outcome in heart transplant patients. Am J Cardiol 87 (2001) 425-431
16. Faulk W.P., Labarrere C.A., Nelson D.R., and Pitts D. Coronary artery disease in cardiac allografts: association with arterial antithrombin. Transplant Proc 27 (1995) 1944-1946
17. Hosmer D.W., and Lemeshow S. Applied regression analysis (2004)
18. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
19. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
20. Labarrere C.A., Pitts D., Nelson D.R., and Faulk W.P. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients. N Engl J Med 333 (1995) 1111-1116
21. Labarrere C.A., Pitts D., Halbrook H., and Faulk W.P. Natural anticoagulant pathways in normal and transplanted human hearts. J Heart Lung Transplant 11 (1992) 342-347
22. Kobashigawa J. What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?. Curr Control Trials Cardiovasc Med 1 (2000) 166-171
23. Wenke K., Meiser B., Thiery J., et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 107 (2003) 93-97
24. Aziz S., Tada Y., Gordon D., McDonald T.O., Fareed J., and Verrier E.D. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine. J Heart Lung Transplant 12 (1993) 634-643